Document is current
Any future updates will be listed below
-
Authors
Lachota, Mieszko
Frajdenberg, Agata
Steiner, Karolina Radl
Hautz, Wojciech
Johansson, Bjorn
Czajka, Marcin Piotr
-
Funding
Funding for this research was provided by:
Fundacja na rzecz Nauki Polskiej (START)
- License Information
-
More Information
Article History
Received: 6 November 2025
Accepted: 21 February 2026
First Online: 11 March 2026
Declarations
:
: Björn Johansson receives consultant fees from Alcon, Bausch & Lomb, Johnson & Johnson, Carl Zeiss Meditec and Théa Laboratoires. Mieszko Lachota is a speaker for TACTICA Pharmaceuticals and Pharmaceutical Works Polpharma. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The Regional Ethical Review Board in Linköping approved the study protocol (registration number M52-08). The study protocol did not require that each patient provide written informed consent.
